Mild stroke symptoms are cited as the reason for not using tissue-type plasminogen activator in 29–43% of time-eligible patients.1 2 Previous studies suggested that not all of these patients had a good recovery or even survive to hospital discharge.3, 6 A large nationwide study (Get With The Guidelines–Stroke) showed that stroke-related disability in mild stroke is relatively common. Here, PLAT is linked to stroke disorder.